RenovoRx (RNXT) Other financing activities (2020 - 2025)
RenovoRx (RNXT) posted Other financing activities of $9000.0 for Q2 2025, up 12.5% sequentially from $8000.0 in Q1 2025, and down 25.0% YoY from $12000.0 in Q2 2024.
RenovoRx (RNXT) Other financing activities (2020 - 2025) Analysis & Trends
RenovoRx has reported Other financing activities for 6 years, with the latest figure at $9000.0 in Q2 2025.
- Quarterly Other financing activities fell 25.0% year-over-year to $9000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $9000.0 (up 1000.0% YoY) and the FY2025 annual result came in at $17000.0, down 48.48% from the prior year.
- Other financing activities rose to $9000.0 in Q2 2025 per RNXT's latest filing, from $8000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $14.5 million in Q3 2021 and troughed at -$5.0 million in Q4 2023.
- A 5-year average of $814611.1 and a median of $8500.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 124700.0% in 2023, down 166500.0% in 2023.
- Over 5 years, Other financing activities stood at $2000.0 in 2021, then jumped by 50.0% to $3000.0 in 2022, then tumbled by 166500.0% to -$5.0 million in 2023, then soared by 99.28% to -$36000.0 in 2024, then soared by 125.0% to $9000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $9000.0, $8000.0, and -$36000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | RenovoRx | 61.96 Mn | 61.96 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | -4.99 Mn |
| Dec 31, 2023 | -4.99 Mn |
| Sep 30, 2023 | 4.99 Mn |
| Sep 30, 2023 | 4.99 Mn |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |